US Patent 10961509 Engineered endothelial cells expressing an ETS transcription factor
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+344 characters)
Article
Patent abstract
In some aspects the present invention relates to engineered endothelial cells, such as E40RF1+ ETV2+ engineered endothelial cells. In other aspects the present invention relates to methods of making such engineered endothelial cells, and methods of using such engineered endothelial cells, for example in co-culture applications.
Edits on 18 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 9 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Claude Geoffrey Davis0
Daniel Joseph Nolan0
Michael Daniel Ginsberg0
Paul William Finnegan0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 11 Feb, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 10961509 Engineered endothelial cells expressing an ETS transcription factor
Infobox
Is a
Patent applicant
Patent jurisdiction
Patent number
10961509
Date of patent
March 30, 2021
Patent application number
15746397
Date Filed
July 19, 2016
Patent primary examiner
Find more entities like US Patent 10961509 Engineered endothelial cells expressing an ETS transcription factor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
